Duchenne muscular dystrophy with associated growth hormone deficiency

Journal of the College of Physicians and Surgeons Pakistan

Volumn 13, Issue 12, 2003, Pages 722-723

  Ghafoor, Tariq ^a   Mahmood, Arshad ^a   Shams, Shahnaz ^a  

^a PNS Shifa ^*  (Pakistan)

Author keywords

Aminotransferase; Duchenne muscular dystrophy; Growth hormone deficiency; Short stature

Indexed keywords

CREATINE KINASE; HUMAN GROWTH HORMONE;

ARTICLE; CASE REPORT; CLINICAL EXAMINATION; CREATINE KINASE BLOOD LEVEL; DISEASE ASSOCIATION; DUCHENNE MUSCULAR DYSTROPHY; ELECTROMYOGRAPHY; FATIGUE; FOLLOW UP; GROWTH HORMONE DEFICIENCY; GROWTH RETARDATION; HORMONE SUBSTITUTION; HUMAN; LIVER FUNCTION TEST; MALE; MUSCLE BIOPSY; MUSCLE WEAKNESS; PATIENT MONITORING; PHYSICAL EXAMINATION; PROVOCATION TEST; SCHOOL CHILD; SYMPTOMATOLOGY;

CHILD; HUMAN GROWTH HORMONE; HUMANS; LIVER FUNCTION TESTS; MALE; MUSCULAR DYSTROPHY, DUCHENNE;

EID: 0442279302     PISSN: 1022386X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (12)

1. Sarnat HB. Neuromuscular disorders. In: Behrman RE, Kliegman RM, Jenson HB, (edi). Nelson textbook of pediatrics, 16th ed. Philadelphia: WB Saunders; 2000;1867-93.
2. Anderson JL, Head SI, Rae C, Morley JW. Brain function in Duchenne muscular dystrophy. Brain 2002; 125:4-13.
3. Essex C, Roper H. Late diagnosis of Duchenne muscular dystrophy presenting as global developmental delay. Br Med J 2001; 323: 37-8.
4. Nagel BH, Mortier W, Elmlinger M, Wollmann HA, Schmitt K, Ranke MB. Short stature in Duchenne muscular dystrophy: a study of 34 patients. Acta Paediatr 1999; 88: 62-5.
5. Zatz M, Betti RT, Levy JA. Benign Duchenne muscular dystrophy in a patient with growth hormone deficiency. Am J Med Genet 1981; 10: 301-4.
6. Stein MT, Tipnis NA, Schultz P. Fatigue, decreased interest in play, motor delay, and elevated liver function tests in a 4-year-old boy. J Dev Behav Pediatr 2002; 23: 37-41.
7. Marconi G, Taiuti R, Sbrilli C, Pizzi A. Becker and limb-girdle muscular dystrophy associated with pituitary dwarfism. J Neurol 1987; 234: 430-2.
8. Zatz M, Betti RT, Frota-Pessoa O. Treatment of Duchenne muscular dystrophy with growth hormone inhibitors. Am J Med Genet 1986; 24: 549-66.
9. Coakley JH, Moorcraft J, Hipkin LJ, Smith CS, Griffiths RD, Edwards RH. The effect of mazindol on growth hormone secretion in boys with Duchenne muscular dystrophy. J Neurol Neurosurg Psychiatry 1988; 51:1551-7.
10. Griggs RC, Moxley RT 3rd, Mendell JR, Fenichel GM, Brooke MH, Miller PJ, et al. Randomized, double-blind trial of mazindol in Duchenne dystrophy. Muscle Nerve 1990; 13:1169-73.
11. Zatz M, Rapaport D, Vainzof M, Pavanello Rde C, Rocha JM, Betti RT, et al. Effect of mazindol on growth hormone levels in patients with Duchenne muscular dystrophy. Am J Med Genet 1988; 31: 821-33.
12. Frank GR, Smith RE. Effective growth hormone therapy in a growth hormone deficient patient with Duchenne muscular dystrophy without evidence of acceleration of the dystrophic process. J